ANYELI BURDIER: Open Payments
NPI 1053848945 · HOLLYWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$923 in 45 payments from 15 companies in 2025. Trend: 2023 $1,023 · 2024 $1,047 · 2025 $923
Food & beverage: $923
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $338 |
| Novo Nordisk Inc | 9 | $177 |
| Amgen Inc. | 5 | $79 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $49 |
| Exact Sciences Corporation | 2 | $44 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28 |
| Abbott Laboratories | 1 | $27 |
| Dynavax Technologies Corporation | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
Products named: FARXIGA, Ozempic, AIRSUPRA, JARDIANCE, Kerendia, REPATHA, Wegovy, SHINGRIX.
Industry payments across FL — which companies pay providers there.
